Presentation Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES May 23, 2017
Presentation EuroPCR 2017 Prasugrel, Ticagrelor and Clopidogrel in PPCI for STEMI: An Analysis of Comparative Clinical Outcomes from the UK BCIS National Registry Presenter: Mamas A. Mamas May 22, 2017
News Conference News EuroPCR 2017 Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate Caitlin E. Cox May 22, 2017
News Daily News Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI Todd Neale May 22, 2017
News Conference News SCAI 2017 Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It L.A. McKeown May 19, 2017
News Conference News EuroPCR 2017 TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS Yael L. Maxwell May 16, 2017
News Daily News $2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor Michael O'Riordan May 12, 2017
News Daily News ‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum Todd Neale April 27, 2017
News Daily News Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes Michael O'Riordan April 27, 2017
Presentation Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD April 25, 2017
News Daily News Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR Shelley Wood April 24, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Daily News Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial Michael O'Riordan March 29, 2017
News Conference News ACC 2017 High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI Michael O'Riordan March 21, 2017
News Conference News ACC 2017 DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions Yael L. Maxwell March 19, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice Caitlin E. Cox March 10, 2017
Presentation 10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents February 13, 2017